Literature DB >> 2815427

Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.

B E Carbin1, P Ekman, P Eneroth, B Nilsson.   

Abstract

Urine-Tissue Polypeptide Antigen (U-TPA) was measured in 81 patients with a previously diagnosed bladder carcinoma. U-TPA was elevated in 74% of the patients with invasive bladder cancer as compared to only 15% of the patients with superficial tumors. Only one patient without a tumor recurrence had an elevated U-TPA level (4%). The results were compared with cytological grading and flow-DNA measurements in a multivariate analysis with T-category as the result variable. U-TPA and grade showed each, independently, a significant relation (P much less than 0.001) to T-category whereas the result of the DNA measurements did not explain the variation in T-category when U-TPA and grade were already in the equation. For diagnostic purposes U-TPA seems to be of limited value but may serve as an indicator of tumor recurrence in bladder cancer patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815427     DOI: 10.1007/BF00262980

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.

Authors:  B BJORKLUND; V BJORKLUND
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

2.  Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium.

Authors:  B E Carbin; V P Collins; P Ekman
Journal:  Urol Res       Date:  1987

3.  Prognostic value of tissue polypeptide antigen in urological neoplasia.

Authors:  C B Costello; S Kumar
Journal:  J R Soc Med       Date:  1985-03       Impact factor: 5.344

4.  Statistical methods in cancer research. Volume I - The analysis of case-control studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1980

5.  Tissue polypeptide antigen (TPA) as a predictor for genitourinary cancers and their metastases.

Authors:  O P Khanna; B Wu
Journal:  Urology       Date:  1987-08       Impact factor: 2.649

6.  A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.

Authors:  C J Menendez-Botet; H F Oettgen; C M Pinsky; M K Schwartz
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

7.  Malignancy grading of epithelial bladder tumours. Reproducibility of grading and comparison between forceps biopsy, aspiration biopsy and exfoliative cytology.

Authors:  C Busch; A Engberg; B J Norlén; B Stenkvist
Journal:  Scand J Urol Nephrol       Date:  1977

8.  Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer.

Authors:  H D Adolphs; P Oehr
Journal:  Urol Res       Date:  1984

9.  The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients.

Authors:  S Kumar; C B Costello; R W Glashan; B Björklund
Journal:  Br J Urol       Date:  1981-12

10.  DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.

Authors:  H Gustafson; B Tribukait; P L Esposti
Journal:  Scand J Urol Nephrol       Date:  1982
View more
  2 in total

1.  Tissue polypeptide antigen and carcinoembryonic antigen lack diagnostic accuracy in urothelial carcinoma.

Authors:  V Stefanović; M Mitić-Zlatković; I Ignjatović; M Vlajković; Z Sćepović
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer.

Authors:  Jamie J D'Costa; James C Goldsmith; Jayne S Wilson; Richard T Bryan; Douglas G Ward
Journal:  Bladder Cancer       Date:  2016-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.